{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:20:44Z","timestamp":1790223644289,"version":"4.1.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117302","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T15:56:19Z","timestamp":1756914979000},"page":"117302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P2","title":["Overcoming standard-of-care resistance in glioblastoma using nanoparticle-based drug delivery targeting the autophagy pathway"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6649-3694","authenticated-orcid":false,"given":"Md Ataur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh Kumar","family":"Yadab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meser M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bcp.2025.117302_b0005","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jamaoncol.2022.2844","article-title":"World Health Organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: a review","volume":"8","author":"Berger","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bcp.2025.117302_b0010","doi-asserted-by":"crossref","unstructured":"Muhsen, A.A. and B.A. Muhsen, Glioblastoma\u2019s Infrequent Locations and Synchronous Tumors. 2025.","DOI":"10.5772\/intechopen.1009146"},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10238-025-01631-0","article-title":"Emerging therapeutic strategies in glioblastsoma: drug repurposing, mechanisms of resistance, precision medicine, and technological innovations","volume":"25","author":"Anwer","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-025-02267-0","article-title":"Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies","volume":"24","author":"Pouyan","year":"2025","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.bcp.2025.117302_b0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/cells14070494","article-title":"Therapeutic targets in glioblastoma: molecular pathways, emerging strategies, and future directions","volume":"14","author":"Tang","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2025.117302_b0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.18632\/oncotarget.28707","article-title":"Imipridones ONC201\/ONC206+ RT\/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT","volume":"16","author":"Zhou","year":"2025","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0035","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/15548627.2022.2105562","article-title":"SDC1-dependent TGM2 determines radiosensitivity in glioblastoma by coordinating EPG5-mediated fusion of autophagosomes with lysosomes","volume":"19","author":"Zheng","year":"2023","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.bcp.2025.117302_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.11.005","article-title":"MST4 phosphorylation of ATG4B regulates autophagic activity, tumorigenicity, and radioresistance in glioblastoma","volume":"32","author":"Huang","year":"2017","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0045","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/cells12030458","article-title":"Recent update and drug target in molecular and pharmacological insights into autophagy modulation in cancer treatment and future progress","volume":"12","author":"Rahman","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bcp.2025.117302_b0050","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s43018-023-00546-7","article-title":"Impact of context-dependent autophagy states on tumor progression","volume":"4","author":"Assi","year":"2023","journal-title":"Nature Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2025.117302_b0055","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3390\/cancers14102416","article-title":"Alterations in molecular profiles affecting glioblastoma resistance to radiochemotherapy: where does the good go?","volume":"14","author":"Vilar","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0060","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70168","article-title":"ADAR1 promotes the progression and temozolomide resistance of glioma through p62\u2010mediated selective autophagy","volume":"31","author":"Zhang","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41419-025-07617-w","article-title":"Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1\u03b1\/HIF2\u03b1 regulation","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0070","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/pharmaceutics17030388","article-title":"Targeting neuroinflammation in central nervous system diseases by oral delivery of lipid nanoparticles","volume":"17","author":"Zou","year":"2025","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.bcp.2025.117302_b0075","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.3390\/ijms26083532","article-title":"Breaking the barrier: the role of proinflammatory cytokines in BBB dysfunction","volume":"26","author":"Gryka-Marton","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117302_b0080","series-title":"Nanoparticles in Modern Neurological Treatment","first-page":"43","article-title":"Nanoparticle-based imaging techniques in neurological disorders","author":"Thangaleela","year":"2025"},{"issue":"12","key":"10.1016\/j.bcp.2025.117302_b0085","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.3390\/cancers13123075","article-title":"Engineered EV-mimetic nanoparticles as therapeutic delivery vehicles for high-grade serous ovarian cancer","volume":"13","author":"Al-Dossary","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bcp.2025.117302_b0090","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3390\/pharmaceutics15041317","article-title":"Natural compounds: co-delivery strategies with chemotherapeutic agents or nucleic acids using lipid-based nanocarriers","volume":"15","author":"Teixeira","year":"2023","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.bcp.2025.117302_b0095","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/biom9100530","article-title":"Autophagy modulators: mechanistic aspects and drug delivery systems","volume":"9","author":"Tavakol","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2025.117302_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102270","article-title":"Nano delivery of natural substances as prospective autophagy modulators in glioblastoma","volume":"29","author":"Agarwal","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"9","key":"10.1016\/j.bcp.2025.117302_b0105","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrd3802","article-title":"Autophagy modulation as a potential therapeutic target for diverse diseases","volume":"11","author":"Rubinsztein","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117302_b0110","doi-asserted-by":"crossref","unstructured":"Ilhan, M. and M. Ozturk, Traditional Medicine and Modern Drug Delivery Systems: Promising Nanotechnology Treatment. Herbal Medicine for Autoimmune Diseases, 2024: p. 85.","DOI":"10.2174\/9789815305005124010008"},{"issue":"17","key":"10.1016\/j.bcp.2025.117302_b0115","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/cancers16172975","article-title":"Recent treatment strategies and molecular pathways in resistance mechanisms of antiangiogenic therapies in glioblastoma","volume":"16","author":"Rahman","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2025.117302_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113740","article-title":"Recent advances in glioblastoma multiforme therapy: a focus on autophagy regulation","volume":"155","author":"Sanati","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bcp.2025.117302_b0125","first-page":"e1220","article-title":"Novel approaches for glioblastoma treatment: focus on tumor heterogeneity, treatment resistance, and computational tools","volume":"2","author":"Valdebenito","year":"2019","journal-title":"Cancer Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0130","first-page":"17","article-title":"Mechanisms of temozolomide resistance in glioblastoma-a comprehensive review","volume":"4","author":"Singh","year":"2021","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.bcp.2025.117302_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1528230","article-title":"The role of autophagy in cancer: from molecular mechanism to therapeutic window","volume":"16","author":"Jalali","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117302_b0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/cells12040535","article-title":"Is autophagy inhibition in combination with temozolomide a therapeutically viable strategy?","volume":"12","author":"Elshazly","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1272\/jnms.JNMS.2024_91-102","article-title":"Molecular mechanisms of macroautophagy, microautophagy, and chaperone-mediated autophagy","volume":"91","author":"Yamamoto","year":"2024","journal-title":"J. Nippon Med. Sch."},{"issue":"11","key":"10.1016\/j.bcp.2025.117302_b0150","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.3390\/biomedicines12112645","article-title":"Advancements in autophagy modulation for the management of oral disease: a focus on drug targets and therapeutics","volume":"12","author":"Rahman","year":"2024","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.bcp.2025.117302_b0155","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202403195","article-title":"Migratory autolysosome disposal mitigates lysosome damage","volume":"223","author":"Sho","year":"2024","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/antiox10030408","article-title":"Antioxidant compound, oxyresveratrol, inhibits APP production through the AMPK\/ULK1\/mTOR-mediated autophagy pathway in mouse cortical astrocytes","volume":"10","author":"Rahman","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bcp.2025.117302_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1506426","article-title":"Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117302_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2025.5502","article-title":"The role of autophagy in fibrosis: mechanisms, progression and therapeutic potential","volume":"55","author":"Chen","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2025.117302_b0175","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/biom15050728","article-title":"Recovery of lysosomal acidification and autophagy flux by attapulgite nanorods: therapeutic potential for lysosomal disorders","volume":"15","author":"Hao","year":"2025","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bcp.2025.117302_b0180","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ijc.34991","article-title":"Autophagy in glioblastoma: a mechanistic perspective","volume":"155","author":"Meena","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2025.117302_b0185","series-title":"Role of Autophagy and Reactive Oxygen Species in Cancer Treatment: Principles and Current Strategies","first-page":"1","article-title":"Autophagy and Reactive Oxygen Species in Cancer: an Introduction","author":"Kumar","year":"2024"},{"key":"10.1016\/j.bcp.2025.117302_b0190","unstructured":"Colella, B., Analysis of autophagy role in glioblastoma biology. 2020."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00018-024-05556-x","article-title":"The interconnective role of the UPS and autophagy in the quality control of cancer mitochondria","volume":"82","author":"Xu","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0200","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/antiox14030264","article-title":"Crosstalk between autophagy and oxidative stress in hematological malignancies: mechanisms, implications, and therapeutic potential","volume":"14","author":"Cabrera-Serrano","year":"2025","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.bcp.2025.117302_b0205","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3390\/biom14080922","article-title":"Complex interplay between DNA damage and autophagy in disease and therapy","volume":"14","author":"Singh","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2025.117302_b0210","article-title":"Role of autophagy in therapeutic resistance of glioblastoma","volume":"5","author":"Chien","year":"2019","journal-title":"J. Cancer Metast. Treat."},{"issue":"4","key":"10.1016\/j.bcp.2025.117302_b0215","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3390\/ijms26041752","article-title":"Emerging role of hypoxia-inducible factors (HIFs) in modulating autophagy: perspectives on cancer therapy","volume":"26","author":"Jalouli","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117302_b0220","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/ijms26052084","article-title":"Inhibition of thioredoxin-reductase by auranofin as a pro-oxidant anticancer strategy for glioblastoma: in vitro and in vivo studies","volume":"26","author":"Chmelyuk","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117302_b0225","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400607","article-title":"Nanomedicine approaches for autophagy modulation in cancer therapy","author":"Mahri","year":"2025","journal-title":"Small Sci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117302_b0230","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/bjc.2016.19","article-title":"Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve","volume":"114","author":"Koukourakis","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41420-023-01573-0","article-title":"Ionizing radiation triggers mitophagy to enhance DNA damage in cancer cells","volume":"9","author":"Ren","year":"2023","journal-title":"Cell Death Discov."},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0240","doi-asserted-by":"crossref","first-page":"260","DOI":"10.20892\/j.issn.2095-3941.2017.0173","article-title":"Autophagic flux response and glioblastoma sensitivity to radiation","volume":"15","author":"Mitrakas","year":"2018","journal-title":"Cancer Biol. Med."},{"issue":"22","key":"10.1016\/j.bcp.2025.117302_b0245","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3390\/cells13221924","article-title":"Emerging role of extracellular pH in tumor microenvironment as a therapeutic target for cancer immunotherapy","volume":"13","author":"Rahman","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2025.117302_b0250","doi-asserted-by":"crossref","unstructured":"Mendoza, E.N., M.R. Ciriolo, and F. Ciccarone, Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It. Antioxidants (Basel), 2025. 14(1).","DOI":"10.3390\/antiox14010094"},{"key":"10.1016\/j.bcp.2025.117302_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216482","article-title":"Autophagy machinery in glioblastoma: the prospect of cell death crosstalk and drug resistance with bioinformatics analysis","volume":"580","author":"Qin","year":"2024","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.bcp.2025.117302_b0260","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00253-019-10257-8","article-title":"Targeting PI3K\/AKT\/mTOR-mediated autophagy for tumor therapy","volume":"104","author":"Xu","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bcp.2025.117302_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.115179","article-title":"Renoprotective effect of berberine in cisplatin-induced acute kidney injury: Role of Klotho and the AMPK\/mtor\/ULK1\/Beclin-1 pathway","volume":"196","author":"Salah","year":"2025","journal-title":"Food Chem. Toxicol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117302_b0270","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5483\/BMBRep.2017.50.7.069","article-title":"Therapeutic implication of autophagy in neurodegenerative diseases","volume":"50","author":"Rahman","year":"2017","journal-title":"BMB Rep."},{"issue":"4","key":"10.1016\/j.bcp.2025.117302_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26041169","article-title":"Challenges and perspectives of standard therapy and drug development in high-grade gliomas","volume":"26","author":"Chelliah","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40164-025-00603-0","article-title":"Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights","volume":"14","author":"Li","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117302_b0285","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.7150\/ijms.94566","article-title":"PI3K\/AKT signaling pathway mediated autophagy in oral carcinoma - a comprehensive review","volume":"21","author":"Rajendran","year":"2024","journal-title":"Int. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2025.117302_b0290","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202300243","article-title":"The molecular mechanisms regulating the assembly of the autophagy initiation complex","volume":"46","author":"Yao","year":"2024","journal-title":"Bioessays"},{"key":"10.1016\/j.bcp.2025.117302_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122613","article-title":"Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: from mechanisms to therapeutics","volume":"345","author":"Thapa","year":"2024","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117302_b0300","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-024-06547-3","article-title":"and Suvorova, II, mTOR pathway occupies a central role in the emergence of latent cancer cells","volume":"15","author":"Aleksandrova","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0305","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00018-025-05634-8","article-title":"AMPK activation by hepatitis E virus infection inhibits viral replication through attenuation of autophagosomes and promotion of innate immunity","volume":"82","author":"Wang","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0310","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s10787-025-01666-5","article-title":"A novel approach to glioblastoma multiforme treatment using modulation of key pathways by naturally occurring small molecules","volume":"33","author":"Afshari","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0315","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12967-024-06063-0","article-title":"Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.bcp.2025.117302_b0320","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10495-018-1480-9","article-title":"Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma","volume":"23","author":"Taylor","year":"2018","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2025.117302_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746621","article-title":"Breaking bad: autophagy tweaks the interplay between glioma and the tumor immune microenvironment","volume":"12","author":"Fan","year":"2021","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.bcp.2025.117302_b0330","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.7150\/ijms.109515","article-title":"Radiotherapy elicits immunogenic cell death and metabolic shifts in the tumor microenvironment: implications for immunotherapy","volume":"22","author":"Hang","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bcp.2025.117302_b0335","unstructured":"Patel, N.H., The role of autophagy and senescence in the responses of non-small cell lung cancer cells to chemotherapy and radiation. 2021."},{"issue":"2","key":"10.1016\/j.bcp.2025.117302_b0340","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MS9.0000000000002888","article-title":"The function of TRIML2 on the temozolomide resistance in glioblastoma","volume":"87","author":"Fu","year":"2025","journal-title":"Ann. Med. Surg. (Lond.)"},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0345","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41573-024-01060-w","article-title":"DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications","volume":"24","author":"Drew","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117302_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0355","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3892\/ol.2017.6107","article-title":"Temozolomide induces autophagy in primary and established glioblastoma cells in an EGFR independent manner","volume":"14","author":"W\u00fcrstle","year":"2017","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.bcp.2025.117302_b0360","doi-asserted-by":"crossref","DOI":"10.3171\/2014.9.FOCUS14504","article-title":"Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy","volume":"37","author":"Golden","year":"2014","journal-title":"Neurosurg. Focus"},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0365","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13409","article-title":"A comprehensive review of sensors of radiation-induced damage, radiation-induced proximal events, and cell death","volume":"329","author":"Saini","year":"2025","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0370","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12944-025-02553-2","article-title":"Radiation induced dermatitis by increasing triglyceride levels to induce autophagy and inhibit the PI3K\/Akt\/mTOR signaling pathway","volume":"24","author":"Hong","year":"2025","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bcp.2025.117302_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.957373","article-title":"Role of autophagy in tumor response to radiation: Implications for improving radiotherapy","volume":"12","author":"Roy","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0380","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13402-024-00969-z","article-title":"Acidity and hypoxia of tumor microenvironment, a positive interplay in extracellular vesicle release by tumor cells","volume":"48","author":"Peppicelli","year":"2025","journal-title":"Cell. Oncol. (Dordr.)"},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e12820","article-title":"Hypoxia-induced autophagy is involved in radioresistance via HIF1A-associated beclin-1 in glioblastoma multiforme","volume":"9","author":"Wei","year":"2023","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0390","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031318","article-title":"Deciphering the role of autophagy in treatment of resistance mechanisms in glioblastoma","volume":"22","author":"Khan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117302_b0395","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2147\/IJN.S243223","article-title":"Nanoparticle drug delivery system for glioma and its efficacy improvement strategies: a comprehensive review","volume":"15","author":"Li","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bcp.2025.117302_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114303","article-title":"Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors - an update","volume":"185","author":"Power","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0405","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2019.11.001","article-title":"Editing cytoprotective autophagy in glioma: an unfulfilled potential for therapy","volume":"26","author":"Ulasov","year":"2020","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0410","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3892\/ijmm.2016.2458","article-title":"Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells","volume":"37","author":"Hu","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117302_b0415","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2018.04.062","article-title":"Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment","volume":"545","author":"Ramalho","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bcp.2025.117302_b0420","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.2147\/IJN.S257459","article-title":"Transferrin receptor-targeted PEG-PLA polymeric micelles for chemotherapy against glioblastoma multiforme","volume":"15","author":"Sun","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"41","key":"10.1016\/j.bcp.2025.117302_b0425","doi-asserted-by":"crossref","first-page":"46290","DOI":"10.1021\/acsami.2c13129","article-title":"Dendrimer-siRNA conjugates for targeted intracellular delivery in glioblastoma animal models","volume":"14","author":"Liyanage","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.bcp.2025.117302_b0430","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020399","article-title":"Curcumin and solid lipid curcumin particles induce autophagy, but inhibit mitophagy and the PI3K-Akt\/mTOR pathway in cultured glioblastoma cells","volume":"20","author":"Maiti","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2025.117302_b0435","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3109\/10717544.2015.1058434","article-title":"Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery","volume":"23","author":"Wu","year":"2016","journal-title":"Drug Deliv."},{"issue":"48","key":"10.1016\/j.bcp.2025.117302_b0440","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1039\/C8TB02390E","article-title":"Gold nanoparticles impair autophagy flux through shape-dependent endocytosis and lysosomal dysfunction","volume":"6","author":"Zhou","year":"2018","journal-title":"J. Mater. Chem. B"},{"issue":"15","key":"10.1016\/j.bcp.2025.117302_b0445","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512052","article-title":"Autophagy inhibition via hydroxychloroquine or 3-methyladenine enhances chemotherapy-induced apoptosis in neuro-blastoma and glioblastoma","volume":"24","author":"Wear","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117302_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174860","article-title":"Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway","volume":"921","author":"Chen","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0455","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12951-017-0261-x","article-title":"Chitosan nanoparticle-mediated co-delivery of shAtg-5 and gefitinib synergistically promoted the efficacy of chemotherapeutics through the modulation of autophagy","volume":"15","author":"Zheng","year":"2017","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bcp.2025.117302_b0460","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.2c10219","article-title":"Immune exosomes loading self-assembled nanomicelles traverse the blood-brain barrier for chemo-immunotherapy against glioblastoma","author":"Cui","year":"2023","journal-title":"ACS Nano"},{"issue":"18","key":"10.1016\/j.bcp.2025.117302_b0465","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.7150\/thno.60437","article-title":"Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cancer progression and metastasis","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.bcp.2025.117302_b0470","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1039\/C4BM00019F","article-title":"Pancreatic cancer gene therapy using an siRNA-functionalized single walled carbon nanotubes (SWNTs) nanoplex","volume":"2","author":"Anderson","year":"2014","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21789","article-title":"Cerium oxide nanoparticles modulating the Parkinson's disease conditions: from the alpha synuclein structural point of view and antioxidant properties of cerium oxide nanoparticles","volume":"10","author":"Yao","year":"2024","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.bcp.2025.117302_b0480","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2217\/nnm-2022-0030","article-title":"Graphene oxide induces autophagy and apoptosis via the ROS-dependent AMPK\/mTOR\/ULK-1 pathway in colorectal cancer cells","volume":"17","author":"Shen","year":"2022","journal-title":"Nanomedicine (Lond.)"},{"issue":"6","key":"10.1016\/j.bcp.2025.117302_b0485","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.18632\/oncotarget.23855","article-title":"Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells","volume":"9","author":"Hsu","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0490","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12035-024-04215-3","article-title":"Revolutionizing stroke care: nanotechnology-based brain delivery as a novel paradigm for treatment and diagnosis","volume":"62","author":"Balaji","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0495","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/01616412.2015.1133025","article-title":"Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation","volume":"38","author":"Ananta","year":"2016","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0500","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030126","article-title":"Dendrimers show promise for siRNA and microRNA therapeutics","volume":"10","author":"Dzmitruk","year":"2018","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.bcp.2025.117302_b0505","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020279","article-title":"Transferrin receptor-targeted nanocarriers: overcoming barriers to treat glioblastoma","volume":"14","author":"Ramalho","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117302_b0510","article-title":"Rapamycin-loaded lipid nanocapsules induce selective Inhibition of the mTORC1-signaling pathway in glioblastoma cells","volume":"8","author":"S\u00e9h\u00e9dic","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0515","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030754","article-title":"Gold nanoparticle-induced cell death and potential applications in nanomedicine","volume":"19","author":"Sun","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.bcp.2025.117302_b0520","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16193300","article-title":"Blood-brain barrier conquest in glioblastoma nanomedicine: strategies, clinical advances, and emerging challenges","volume":"16","author":"Duan","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0525","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/17425247.2016.1220364","article-title":"Pathways of protein and lipid receptor-mediated transcytosis in drug delivery","volume":"14","author":"Thuenauer","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"issue":"6","key":"10.1016\/j.bcp.2025.117302_b0530","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1537-1891(02)00202-1","article-title":"Drug delivery to brain via the blood-brain barrier","volume":"38","author":"Scherrmann","year":"2002","journal-title":"Vascul. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117302_b0535","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1039\/D2BM01996E","article-title":"Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery","volume":"11","author":"Nozhat","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bcp.2025.117302_b0540","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.addr.2016.08.014","article-title":"Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes","volume":"113","author":"Wang","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.bcp.2025.117302_b0545","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1021\/acs.biomac.4c00722","article-title":"Stimuli-responsive polymeric nanocarriers accelerate on-demand drug release to combat glioblastoma","volume":"25","author":"Ismail","year":"2024","journal-title":"Biomacromolecules"},{"issue":"8","key":"10.1016\/j.bcp.2025.117302_b0550","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1021\/acs.bioconjchem.3c00266","article-title":"Matrix metalloproteinase-responsive drug delivery systems","volume":"34","author":"Zhang","year":"2023","journal-title":"Bioconjug. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2025.117302_b0555","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032496","article-title":"Recent advances on surface-modified GBM targeted nanoparticles: targeting strategies and surface characterization","volume":"24","author":"Rod\u00e0","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117302_b0560","first-page":"325","article-title":"Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas","volume":"20","author":"Wang","year":"2023","journal-title":"Cancer Biol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2025.117302_b0565","first-page":"2052","article-title":"Effect of siRNA-induced Atg7 gene silencing on the sensitivity of ovarian cancer SKOV3 cells to cisplatin","volume":"12","author":"Zhang","year":"2020","journal-title":"Am. J. Transl. Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.117302_b0570","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3892\/etm.2016.3196","article-title":"Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy","volume":"11","author":"Bak","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bcp.2025.117302_b0575","first-page":"1","article-title":"Araloside a induces Raf\/MEK\/ERK-dependent autophagy to mitigate Alzheimer\u2019s and Parkinson\u2019s pathology in cellular and C. elegans models","author":"Chen","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0580","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bdd.2345","article-title":"Recent advances in the in vitro and in vivo methods to assess impact of P-glycoprotein and breast cancer resistance protein transporters in central nervous system drug disposition","volume":"44","author":"Chatterjee","year":"2023","journal-title":"Biopharm. Drug Dispos."},{"issue":"12","key":"10.1016\/j.bcp.2025.117302_b0585","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304180","article-title":"Nanomaterials as microglia modulators in the treatment of central nervous system disorders","volume":"13","author":"Battaglini","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"18","key":"10.1016\/j.bcp.2025.117302_b0590","doi-asserted-by":"crossref","first-page":"16416","DOI":"10.1021\/acs.jmedchem.4c01265","article-title":"Transferrin-modified carprofen platinum (IV) nanoparticles as antimetastasis agents with tumor targeting, inflammation inhibition, epithelial\u2013mesenchymal transition suppression, and immune activation properties","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0595","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41401-024-01356-y","article-title":"Natural autophagy modulators in non-communicable diseases: from autophagy mechanisms to therapeutic potential","volume":"46","author":"Xu","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2025.117302_b0600","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3389\/fphar.2020.00787","article-title":"The exploitation of liposomes in the inhibition of autophagy to defeat drug resistance","volume":"11","author":"Condello","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117302_b0605","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1548588","article-title":"Nanotechnology in cancer treatment: revolutionizing strategies against drug resistance","volume":"13","author":"Sabir","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bcp.2025.117302_b0610","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coph.2021.08.019","article-title":"Three-dimensionalculture models to study glioblastoma - current trends and future perspectives","volume":"61","author":"Joseph","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117302_b0615","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13578-023-00986-9","article-title":"Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective","volume":"13","author":"L\u00f3pez-M\u00e9ndez","year":"2023","journal-title":"Cell Biosci."},{"issue":"8","key":"10.1016\/j.bcp.2025.117302_b0620","article-title":"Temozolomide and chloroquine co-loaded mesoporous silica nanoparticles are effective against glioma","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.bcp.2025.117302_b0625","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3390\/cells13100823","article-title":"Glioblastoma phagocytic cell death: balancing the opportunities for therapeutic manipulation","volume":"13","author":"Du","year":"2024","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.bcp.2025.117302_b0630","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s10495-021-01691-z","article-title":"Regulation of autophagy as a therapeutic option in glioblastoma","volume":"26","author":"Manea","year":"2021","journal-title":"Apoptosis"},{"issue":"18","key":"10.1016\/j.bcp.2025.117302_b0635","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/smll.200900466","article-title":"Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage","volume":"5","author":"Pan","year":"2009","journal-title":"Small"},{"issue":"12","key":"10.1016\/j.bcp.2025.117302_b0640","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1021\/bm900683r","article-title":"Cationic poly(amidoamine) dendrimer induces lysosomal apoptotic pathway at therapeutically relevant concentrations","volume":"10","author":"Thomas","year":"2009","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.bcp.2025.117302_b0645","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1021\/acsnano.2c12193","article-title":"Antibodies against poly(ethylene glycol) activate innate immune cells and induce hypersensitivity reactions to PEGylated nanomedicines","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bcp.2025.117302_b0650","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/pharmaceutics14020247","article-title":"The Hitchhiker\u2019s guide to human therapeutic nanoparticle development","volume":"14","author":"Ramos","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117302_b0655","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1529468","article-title":"Innovative applications and future perspectives of chromatography-mass spectrometry in drug research","volume":"16","author":"Cai","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117302_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108702","article-title":"Advances in artificial intelligence for drug delivery and development: a comprehensive review","volume":"178","author":"Gholap","year":"2024","journal-title":"Comput. Biol. Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T05:19:56Z","timestamp":1761455996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225005672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":132,"alternative-id":["S0006295225005672"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117302","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming standard-of-care resistance in glioblastoma using nanoparticle-based drug delivery targeting the autophagy pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117302"}}